FDA Inspection 1273730 — Seattle Reproductive Medicine, Inc., P.S.
The FDA completed an inspection of Seattle Reproductive Medicine, Inc., P.S. on June 11, 2025 in Spokane Valley, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 11, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Spokane Valley, WA (United States)